Works matching DE "MANTLE cell lymphoma"

Results: 1212
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: updated results from the phase 1/2 BRUIN study.

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
    By:
    • Jurczak, Wojciech;
    • Wang, Michael;
    • Shah, Nirav;
    • Alencar, Alvaro;
    • Gerson, James;
    • Patel, Manish;
    • Fakhri, Bita;
    • Xuan Tan;
    • Lewis, Katharine;
    • Flinn, Ian;
    • Lewis, Davud;
    • Le Gouill, Steven;
    • Palomba, Lia;
    • Woyach, Jennifer;
    • Pagel, John;
    • Lamanna, Nicole;
    • Cohen, Johnathon;
    • Barve, Minal;
    • Ghia, Paolo;
    • Eyre, Toby
    Publication type:
    Article
    13

    Primary results from the double-blind, placebo-controlled, phase 3 SHINE study of ibrutinib in combination with bendamustine-rituximab (BR) and R maintenance as a first-line treatment for older patients with mantle cell lymphoma (MCL).

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
    By:
    • Jurczak, Wojciech;
    • Gouill, Steven Le;
    • Jerkeman, Mats;
    • Trotman, Judith;
    • Zinzani, Pier Luigi;
    • Belada, David;
    • Boccomini, Carola;
    • Flinn, Ian W.;
    • Giri, Pratyush;
    • Goy, Andre;
    • Hamlin, Paul A.;
    • Hermine, Olivier;
    • Hernández-Rivas, José-ángel;
    • Xiaonan Hong;
    • Seok Jin Kim;
    • Lewis, David;
    • Yuko Mishima;
    • Özcan, Muhit;
    • Perini, Guilherme Fleury;
    • Pocock, Christopher
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Gemellus.

    Published in:
    Colorectal Disease, 2019, v. 21, n. 10, p. 1227, doi. 10.1111/codi.14646
    Publication type:
    Article
    25
    26
    27
    28

    Increased tumour angiogenesis in SOX11‐positive mantle cell lymphoma.

    Published in:
    Histopathology, 2019, v. 75, n. 5, p. 704, doi. 10.1111/his.13935
    By:
    • Petrakis, Georgios;
    • Veloza, Luis;
    • Clot, Guillem;
    • Gine, Eva;
    • Gonzalez‐Farre, Blanca;
    • Navarro, Alba;
    • Bea, Silvia;
    • Martínez, Antonio;
    • Lopez‐Guillermo, Armando;
    • Amador, Virginia;
    • Ribera‐Cortada, Inmaculada;
    • Campo, Elias
    Publication type:
    Article
    29

    Aberrant expression of CD10 and BCL6 in mantle cell lymphoma.

    Published in:
    Histopathology, 2017, v. 71, n. 5, p. 769, doi. 10.1111/his.13286
    By:
    • Pizzi, Marco;
    • Agostinelli, Claudio;
    • Righi, Simona;
    • Gazzola, Anna;
    • Mannu, Claudia;
    • Galuppini, Francesca;
    • Fassan, Matteo;
    • Visentin, Andrea;
    • Piazza, Francesco;
    • Semenzato, Gianpietro C;
    • Rugge, Massimo;
    • Sabattini, Elena
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.

    Published in:
    Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01520-7
    By:
    • Vose, Julie M.;
    • Fu, Kai;
    • Wang, Lu;
    • Mansoor, Adnan;
    • Stewart, Douglas;
    • Cheng, Hongxia;
    • Smith, Lynette;
    • Yuan, Ji;
    • Qureishi, Hina Naushad;
    • Link, Brian K.;
    • Cessna, Melissa H.;
    • Barr, Paul M.;
    • Kahl, Brad S.;
    • Mckinney, Matthew S.;
    • Khan, Nadia;
    • Advani, Ranjana H.;
    • Martin, Peter;
    • Goy, Andre H.;
    • Phillips, Tycel J.;
    • Mehta, Amitkumar
    Publication type:
    Article
    41
    42
    43

    Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01257-9
    By:
    • Jiang, Vivian Changying;
    • Liu, Yang;
    • Jordan, Alexa;
    • Leeming, Angela;
    • McIntosh, Joseph;
    • Huang, Shengjian;
    • Zhang, Rongjia;
    • Cai, Qingsong;
    • Chen, Zhihong;
    • Li, Yijing;
    • Che, Yuxuan;
    • Nie, Lei;
    • Karlsson, Ingrid;
    • Mårtensson, Linda;
    • Kovacek, Mathilda;
    • Teige, Ingrid;
    • Frendéus, Björn;
    • Wang, Michael
    Publication type:
    Article
    44

    Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study.

    Published in:
    Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01188-x
    By:
    • Wang, Michael;
    • Ramchandren, Radhakrishnan;
    • Chen, Robert;
    • Karlin, Lionel;
    • Chong, Geoffrey;
    • Jurczak, Wojciech;
    • Wu, Ka Lung;
    • Bishton, Mark;
    • Collins, Graham P.;
    • Eliadis, Paul;
    • Peyrade, Frédéric;
    • Lee, Yihua;
    • Eckert, Karl;
    • Neuenburg, Jutta K.;
    • Tam, Constantine S.
    Publication type:
    Article
    45
    46

    Metástasis mamaria de linfoma de células del manto.

    Published in:
    Ginecología y Obstetricia de México, 2018, v. 86, n. 11, p. 740, doi. 10.24245/gom.v86i11.1979
    By:
    • Dardano-Berrie, Andrés;
    • Curbelo-Peña, Yuhamy;
    • Guerrero-López, Raúl;
    • Stickar, Tomas;
    • Gardenyes-Martínez, Julia;
    • Vallverdú-Cartie, Helena
    Publication type:
    Article
    47
    48
    49
    50